"
Team:UT-Tokyo/CTCD/Content/Result
From 2014.igem.org
<img src="
" class = "contTitle" />
Our aim was to make a construct like below.(fig.1)
<img src="
" class = "figure" />
miRNA142-5p sequence is CAUAAAGUAGAAAGCACUACU .
miRNA142-3p sequence is UGUAGUGUUUCCUACUUUAUGGA.
The target sequence is the complementary to the miRNA142-5p and miRNA142-3p sequence.
miRNA142-5p binding site is AGTAGTGCTTTCTACTTTATG.
miRNA142-3p binding site is TCCATAAAGTAGGAAACACTACA.
We constructed miRNA-binding sites by annealing the two oligos shown below.
5’-GCGGAATTCGCGGCCGCTTCTAGAGCATAAAGTAGAAAGCACTACTTACTAGTAGCGGCCGCTGCAGGCG-3’
5’-CGCCTGCAGCGGCCGCTACTAGTAAGTAGTGCTTTCTACTTTATGCTCTAGAAGCGGCCGCGAATTCCGC-3’
When we made miRNA-binding site connected tandemly, we couldn’t use PCR or gel extraction because they contained repeats and short sequences . So we had to anneal two oligos and insert in the plasmid.(fig.2)
<img src="
" class = "figure" />
This method can be used for other miRNA-binding sites or other parts not suitable for PCR or gel extraction .
Constructs we planed to use in this experiment were already made apart from EGP-2 promoter, and sequences were confirmed. But cloning of EGP-2 was not successful.
So we have to clone EGP-2 promoter, make the construct,and perform reporter assay before our presentation.
